Feasibility and benefits of home initiation of subcutaneous apomorphine infusion for patients with Parkinson’s disease: the APOKADO study
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Feasibility and benefits of home initiation of subcutaneous apomorphine infusion for patients with Parkinson’s disease: the APOKADO study
Authors
Keywords
-
Journal
JOURNAL OF NEURAL TRANSMISSION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-03-02
DOI
10.1007/s00702-023-02609-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pompe à apomorphine au stade terminal de la maladie de Parkinson
- (2022) Matthieu Béreau et al. REVUE NEUROLOGIQUE
- Neurologists’ preferences for device-aided therapy for advanced Parkinson’s disease in Japan
- (2022) Shinsuke Fujioka et al. CURRENT MEDICAL RESEARCH AND OPINION
- COVID-19 and Parkinson’s disease: a systematic review and meta-analysis
- (2022) Maryam Afraie et al. ACTA NEUROLOGICA BELGICA
- Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study
- (2021) Regina Katzenschlager et al. PARKINSONISM & RELATED DISORDERS
- A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK study
- (2021) Margherita Fabbri et al. PARKINSONISM & RELATED DISORDERS
- Long-term effect of apomorphine infusion in advanced Parkinson’s disease: a real-life study
- (2021) Bruna Meira et al. npj Parkinsons Disease
- Continuous Subcutaneous Apomorphine Infusion in Parkinson’s Disease: A Single-Center, Long-Term Follow-Up Study of the Causes for Discontinuation
- (2021) Tove Henriksen et al. Journal of Personalized Medicine
- Early factors for predicting discontinuation to subcutaneous Apomorphine infusion in Parkinson's disease: A prospective analysis of the Thai Apomorphine Registry
- (2021) Onanong Phokaewvarangkul et al. PARKINSONISM & RELATED DISORDERS
- Integrated and patient-centred management of Parkinson's disease: a network model for reshaping chronic neurological care
- (2020) Bastiaan R Bloem et al. LANCET NEUROLOGY
- EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease
- (2019) Haidar S. Dafsari et al. MOVEMENT DISORDERS
- Correction to: Continuous subcutaneous apomorphine infusion in Parkinson’s disease: causes of discontinuation and subsequent treatment strategies
- (2019) Enrica Olivola et al. NEUROLOGICAL SCIENCES
- The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future
- (2018) Manon Auffret et al. Drugs in research & development
- Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial
- (2018) Regina Katzenschlager et al. LANCET NEUROLOGY
- Effects of continuous subcutaneous apomorphine infusion in Parkinson's disease without cognitive impairment on motor, cognitive, psychiatric symptoms and quality of life
- (2018) Jean-François Houvenaghel et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Long-term adherence to apomorphine infusion in patients with Parkinson disease: a 10-year observational study
- (2017) Thomas E. Kimber et al. INTERNAL MEDICINE JOURNAL
- Continuous subcutaneous apomorphine infusion in advanced Parkinson’s disease: 10-year experience with 230 patients
- (2017) Ángel Sesar et al. JOURNAL OF NEUROLOGY
- Changes in Quality of Life in Parkinson's Disease: How Large Must They Be to Be Relevant?
- (2017) Krisztina Horváth et al. NEUROEPIDEMIOLOGY
- Continuous subcutaneous apomorphine infusion in Parkinson's disease patients with cognitive dysfunction: A retrospective long-term follow-up study
- (2017) Robbert W.K. Borgemeester et al. PARKINSONISM & RELATED DISORDERS
- Quality of life in Parkinson’s disease improved by apomorphine pump: the OPTIPUMP cohort study
- (2016) Sophie Drapier et al. JOURNAL OF NEUROLOGY
- The efficacy of apomorphine – A non-motor perspective
- (2016) Miguel Rosa-Grilo et al. PARKINSONISM & RELATED DISORDERS
- Understanding the role of the Parkinson's disease nurse specialist in the delivery of apomorphine therapy
- (2016) Roongroj Bhidayasiri et al. PARKINSONISM & RELATED DISORDERS
- Motor and non-motor outcomes of continuous apomorphine infusion in 125 Parkinson's disease patients
- (2016) Robbert W.K. Borgemeester et al. PARKINSONISM & RELATED DISORDERS
- Effective Delivery of Apomorphine in the Management of Parkinson Disease
- (2015) Roongroj Bhidayasiri et al. CLINICAL NEUROPHARMACOLOGY
- Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease – Clinical practice recommendations
- (2015) Claudia Trenkwalder et al. PARKINSONISM & RELATED DISORDERS
- EuroInf: AMulticenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease
- (2014) Pablo Martinez-Martin et al. MOVEMENT DISORDERS
- Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson’s disease in the UK and Germany
- (2014) Evelyn Walter et al. JOURNAL OF MEDICAL ECONOMICS
- Subcutaneous infusions of apomorphine: a reappraisal of its therapeutic efficacy in advanced Parkinson’s disease
- (2013) Francisco Grandas Expert Review of Neurotherapeutics
- Effectiveness of multidisciplinary interventions to improve the quality of life for people with Parkinson's disease: A systematic review
- (2013) Siok Bee Tan et al. INTERNATIONAL JOURNAL OF NURSING STUDIES
- The Pharmacological Properties and Therapeutic Use of Apomorphine
- (2012) Samo Ribarič MOLECULES
- Cost analysis of the treatments for patients with advanced Parkinson's disease: SCOPE study
- (2012) Francesc Valldeoriola et al. JOURNAL OF MEDICAL ECONOMICS
- Dopamine Agonist Withdrawal Syndrome in Parkinson Disease
- (2010) Christina A. Rabinak et al. ARCHIVES OF NEUROLOGY
- The pragmatic use of apomorphine at the end of life
- (2009) F. Dewhurst et al. PALLIATIVE MEDICINE
- Continuous subcutaneous infusion of apomorphine can be used safely in patients with Parkinson's disease and pre-existing visual hallucinations
- (2009) Teus van Laar et al. PARKINSONISM & RELATED DISORDERS
- Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study
- (2008) Pedro J. García Ruiz et al. MOVEMENT DISORDERS
- Ultrasound treatment of cutaneous side-effects of infused apomorphine: A randomized controlled pilot study
- (2008) Leon Poltawski et al. MOVEMENT DISORDERS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started